Showing all 2 results
Rifampicin & Isoniazid Tablets
FreeProduct Composition & Standard Compendial Configurations
We supply this FDC in the internationally recognized, World Health Organization (WHO) recommended dosage strengths calibrated to support exact adult and pediatric weight-band categories.
Active Ingredients Monograph Available Strengths Formulation Matrix Delivery System Primary Clinical Application Rifampicin + Isoniazid BP/USP/IP 150 mg + 75 mg Oral Solid Film-Coated Tablet Adult Continuation Phase: Standard international baseline configuration utilized daily for the 4-month consolidation phase of pulmonary tuberculosis. Rifampicin + Isoniazid BP/USP/IP 300 mg + 150 mg Oral High-Mass Film-Coated Tablet High-Weight Adult Maintenance: High-potency format optimized to ensure single-tablet compliance for patients in higher weight bands. Rifampicin + Isoniazid BP/USP/IP 60 mg + 30 mg / 60 mg + 60 mg Oral Solid Soluble / Dispersible Tablet Pediatric Regimen Management: Fruit-flavored, water-soluble dispersible matrices engineered for exact dose compliance in pediatric networks. Rifampicin, Isoniazid & Pyrazinamide Tablets
FreeProduct Composition & Strength
We supply this product as Film Coated Tablets (Red/Brown). Stability is paramount as Rifampicin can degrade in the presence of Isoniazid if not properly formulated.
Active Ingredient Strength (Standard Adult) Strength (Pediatric) Therapeutic Role Rifampicin IP/BP/USP 150 mg 75 mg / 60 mg Broad Spectrum Sterilizer Isoniazid IP/BP/USP 75 mg 50 mg / 30 mg Cell Wall Inhibitor Pyrazinamide IP/BP/USP 400 mg 150 mg Intracellular Sterilizer Excipients Q.S. Ascorbic Acid (Stabilizer) Bioavailability Enhancer
